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Background & aims: Mortality among patients with chronic heart failure (CHF) is still high despite
progress in medical and surgical treatment. The patients' nutritional condition may play an important
role, and needs further investigation. The aim of this study was to evaluate whether nutritional risk in
hospitalized patients with CHF was associated with three-year mortality.
Methods: A prospective study was conducted in 131 hospitalized Norwegian patients with CHF. Nutri-
tional screening was performed using Nutritional Risk Screening (NRS-2002). The primary clinical
outcome was death from any cause.
Results: The prevalence of nutritional risk was 57% (NRS-2002 score  3). The overall mortality rate was
52.6% within three-year follow up. More patients at nutritional risk (N ¼ 51) died compared to patients
not at nutritional risk (N ¼ 18) (P < 0.001). In adjusted analyses patients at nutritional risk had more than
ﬁve-time higher odds (OR 5.85; 95% CI 2.10e16.24) to die before three-year follow-up than those not at
nutritional risk. In adjusted Cox multivariate analysis, the nutritional risk was associated with increased
mortality (HR 2.78; 95% CI 1.53e5.03). Furthermore, in adjusted analysis components in NRS-2002 were
associated with mortality, i.e. nutritional status (HR 1.82; 95% CI 1.03e3.22), severity of disease (NYHA-
class IV) (HR 1.78; 95% CI 1.00e3.16) and age ( 70 year) (HR 3.24; 95% CI 1.48e7.10).
Conclusion: Nutritional risk as deﬁned by NRS-2002 in hospitalized patients with CHF was signiﬁcantly
associated with long term mortality.
© 2016 The Authors. Published by Elsevier Ltd. on behalf of European Society for Clinical Nutrition and
Metabolism. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Chronic heart failure (CHF) is characterized by high mortality,
multiple comorbidities, a complex therapeutic regimen, frequent
hospitalization and reduced quality of life [1]. Implementation of
guideline-recommended pharmacologic and non-pharmacologic
therapies [2] has signiﬁcantly improved survival among CHF pa-
tients, but the mortality rate is still high [3,4]. Known predictors of
mortality in patients with CHF are older age [5,6], diabetes [5,6],
lower left ventricular ejection fraction (EF) [5,6], higher New York
Heart Association classiﬁcation (NYHA class) [5], elevated N-ter-
minal pro-B-type natriuretic peptide (NT-proBNP) [7,8], frailty [9]
and cardiac cachexia [10,11]. Observational studies also indicatefor Clinical Nutrition and Metabolism. This is an open access article under the CC BY-
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levels of BMI [5,6,12e14], total cholesterol [13,15] and systolic blood
pressure [13]. This inverse relationship between traditional car-
diovascular risk factor and mortality in the heart failure patient has
been described as “reverse epidemiology” [13].
In addition, poor nutritional conditions have in several studies
been strongly associated with mortality in hospitalized patients
with CHF [16e19]. At two [16] and three [17,19] years follow up the
mortality in CHF patients with a poor nutritional condition has
been found to vary between 26.5 and 76%. Furthermore, the prev-
alence of nutritional risk in hospitalized patients with CHF has been
found to vary between 34 and 90% [16e20].
Several screening tools have been designed to assess the pa-
tient's nutritional risk, like Mini Nutritional Assessment (MNA),
Subjective Global Assessment (SGA), Malnutrition Universal
Screening Tool (MUST) and Nutritional Risk Screening (NRS-2002)
[21]. The screening tool NRS-2002 was designed and validated by
the European Society for Clinical Nutrition andMetabolism (ESPEN)
[21,22], and is recommended for use in the hospital setting [21].
NRS-2002 is shown to provide a simple and rapid screening of
hospitalized patients [21,22]. ESPEN has described the purpose of
nutritional screening as a method “to predict the probability of a
better or worse outcome due to nutritional factors, and whether
nutritional treatment is likely to inﬂuence this” [21, s. 415].
MUST is recommended by ESPEN as a screening tool for the
community [21]. The screening tools SGA and MNA are used in
hospital settings, but may be more time consuming compared with
NRS-2002. In a hospital setting it therefore would be an advantage
using NRS-2002 to obtain a rapid and easy screening [21].
NRS-2002 has previously been validated in different hospital
settings [23]. Recently, it was evaluated in CHF patients and found
adequate to detect nutritional risk in these patients [24]. The pre-
dictive validity of nutritional screening tools has often been eval-
uated against clinical outcome, and especially mortality has been
investigated in relation to nutritional risk [25]. In a meta-analysis
NRS-2002 has shown fair to good predictive validity to predict in-
hospital mortality for adult patients [23]. The association be-
tween NRS-2002 and long termmortality (>12 months) is yet to be
conﬁrmed in most groups of patients. As far as we know mortality
has not been investigated in a CHF sample using the NRS-2002.
The primary objective of this study was therefore to explore the
association between nutritional risk assessed with NRS-2002 at
admittance to hospital and three-year overall mortality in patients
with CHF. In addition we wanted to investigate the association
between mortality and the three different components in NRS-
2002 (nutritional status, severity of disease and age).
2. Materials and methods
2.1. Design
An observational study with three-year follow-up was per-
formed based on hospitalized CHF patients at St. Olav's University
Hospital in Trondheim, Norway. The recruitment period was be-
tween October 2008 and February 2010.
2.2. Participants
CHF was diagnosed according to the recommendation of the
European Society of Cardiology [26]. The CHF patients were clas-
siﬁed according to the international statistical classiﬁcation of
diseases (ICD-10) for the diagnoses of heart failure (I50) [27]. The
following criteria were used to identify hospitalized patients with
CHF eligible for the study: 1) directly admitted to the department of
cardiology, St. Olav's University Hospital, 2) age > 18 years, 3) heartfailure  3 months, 4) ejection fraction (EF)  50% and 5) NYHA
classiﬁcation II, III or IV [28].
In our study a total of 131 patients were included. Fig. 1 (ﬂow-
charts) gives a detailed description of excluded patients (N ¼ 157).2.3. Variables
2.3.1. New York Heart Failure Association classiﬁcation (NYHA-
class)
Heart failure severity was divided into four categories according
to the NYHA-classiﬁcation. NYHA-class I ¼ no symptoms during
ordinary physical activity; NYHA-class II ¼ slight limitation during
ordinary physical activity; NYHA-class III ¼ marked limitation dur-
ing ordinary physical activity; NYHA-class IV ¼ inability to carry on
any physical activity without discomfort or discomfort at rest [28].2.3.2. Medication
Information about beta-blockers and angiotensin-converting-
enzyme (ACE) inhibitors was obtained from the patient's records
at screening time.2.3.3. Ejection fraction
Ejection fraction (EF) was measured using cardiac ultrasound
(Echocardiography). At the cardiac medical outpatient clinic at St.
Olav's University Hospital all examinations were done by a cardi-
ologist. EF was obtained from the standardized ultrasound result
record.
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The day after inclusion, morning serum albumin, pre-albumin,
C-reactive protein (CRP) and cholesterol were analyzed. Albumin
was analyzed according to standard procedure at St. Olav's Uni-
versity Hospital [29] using bromocresol green method and the
analysis instrument Roche Modular P [29]. Pre-albumin was
analyzed by an immunological method. Dade-Behring Nephelom-
eter PROSPEC was used as an analytical instrument [29]. CRP was
also analyzed with immunologic method and by the analysis in-
strument RocheModular P [29]. Cholesterol was analyzed using the
analysis instrument Roche Modular P [29].2.3.5. Comorbidity
In our study the comorbidity variables were diabetes (yes/no),
renal failure with creatinine < 330 mmol/L (yes/no), COPD grade I or
II versus no, and hypertension (yes/no).2.3.6. Anthropometry
In the morning, before breakfast, the patients were weighed
without shoes with light clothes on a portable Seca digital scale to
the nearest 0.1 kg. The weight was standardized and controlled.
Height was measured with Seca stadiometer to the nearest cm. The
following formula was used to calculate body mass index (BMI):
BMI ¼ weight (kg)/height (m)2 [30].2.3.7. Weight loss
Percent weight loss was estimated using the formula:
(weight loss/earlier weight)  100 ¼ weight loss in %.
Self-reported weight was used to calculate percentage weight
loss.2.3.8. Nutritional screening
According to Kondrup et al. [21,22], the nutritional risk score in
NRS-2002 is based on an evaluation of the following three com-
ponents: nutritional status, severity of disease and age. The patients
are given a score from 0 to 3 for nutritional status, and from 0 to 3
for the severity of disease. A score of 1 is added to patients 70 years
and older. The total score is from 0 to 7, and if the sum score is 3 or
more, the patient is classiﬁed at nutritional risk by NRS-2002.
Nutritional status in NRS-2002 is evaluated by three individual
components: BMI, recent weight loss ( 5% within the last 1, 2 or 3
months) and food intake the preceding week. Information about
food intake during the week prior to admission was obtained by a
special nurse (trained by a dietitian), using an interview with the
patient. The questions focusing on food intake prior to hospitali-
zation were compared with normal intake. Furthermore, the food
intake was categorized into 0e25%, 25e50% and 50e75% of normal
requirement [21,22]. The inter-rater reliability of NRS-2002 be-
tween the trained special nurse and a dietitian was documented to
be substantial with a kappa value of 0.81 in our previous published
work [24].
In our study the scoring system of severity of disease was based
on the patient's NYHA-classiﬁcation [28] and Kondrup et al.'s
prototype of score 1, 2 or 3 on severity of disease [22, s. 330]. Pa-
tients in NYHA-class II or III had a reduced state of health, but were
regularly out of bed and received score 1. Most of the patients in
NYHA-class IV were conﬁned to bed due to illness and received
score 2. Score 3 should be given to patients in NYHA-class IV and in
need of intensive care treatment.2.3.9. Nutritional intervention
During the hospital period we registered the nutritional treat-
ment the patient received such as oral nutritional supplements,
enteral tube feeding or parenteral nutrition which were docu-
mented in the hospital record. In additionwe registered if a patient
had received ICD-10 code formild, moderate or severemalnutrition
(E43, E44.0, E44.1) in the discharge summary.
2.3.10. Mortality
In Norway all deaths are registered in a central Cause of Death
registry. The registry is complete. Data are transferred electroni-
cally to the hospital administrative system based on the national 11
digit identity number. Deaths both in and out of hospital are
registered. Survival was conﬁrmed through the Norwegian Cause of
Death Registry.
2.4. Procedure
Informed written consent was obtained from each patient.
Within 72 h of admission nutritional screening was performed
using the NRS-2002. The nutritional screening with NRS-2002 and
the measurements of weight and height was completed by one
investigator (KT). Time of death was obtained from all participants
during the three-year (1095 days) follow-up (KT).
The Regional Research Ethics Committee and the Norwegian
Social Science Data Services approved the study.
2.5. Statistical analysis
The data was analyzed with SPSS, version 22. Results were
considered signiﬁcant when P < 0.05. Normally distributed
continuous data were analyzed by two-tailed independent t-test.
The remaining independent continuous data were analyzed by
ManneWhitney U Test. Categorical data were analyzed by the Chi-
Square Test or by the Fisher Exact test (depending on sample size).
All participants were followed for three years (1095 days) after
nutritional screening with NRS-2002. KaplaneMeier survival
curves describing three-year mortality were obtained for the two
groups according to the NRS-2002 classiﬁcation (NRS-2002 < 3
versus NRS-2002  3). In addition we used KaplaneMeier survival
curves to investigate the association between three-year mortality,
nutritional status (score 0 versus score 1, 2 or 3 on nutritional
status) and the three individual nutritional components in NRS-
2002 (food intake > 75% versus  75% of normal requirement in
the preceding week, weight loss < 5% versus  5% last 1e3 months
and BMI > 20.5 versus BMI  20.5). Log Rank (ManteleCox) was
used to test the mortality differences between the groups pre-
sented in the KaplaneMeier survival curves.
Mortality was ﬁrst studied using binary logistic regression
analysis (the ‘Enter’ method) in order to estimate the risk of three-
year mortality (yes/no). In the bivariate analysis the independent
variables NRS-2002, gender, EF, beta-blocker, ACE-inhibitor, albu-
min, pre-albumin, CRP, cholesterol and comorbidity (diabetes, renal
failure with creatinine < 330 mmol/L, COPD grade I or II, hyper-
tension) were studied. The independent variables with P < 0.2 were
included in the ﬁnal multivariate model. Results are presented as
odds ratio (OR) with conﬁdence intervals (CI) of 95%.
Thereafter, the time to death was studied using Cox propor-
tional hazard regression analysis. This analysis takes into account
both the importance of baseline vital status and the time before
the event occurs. The same initial independent variables, the
same reference levels and the same assumptions for inclusion in
further analyses were used in this assessment method as in the
logistic regression analyses. In addition, the three components of
NRS-2002 (score of nutritional status, severity of disease and
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ﬁnally chosen in the presented adjusted analyses rather than the
sum-score of NRS-2002. The results are given in hazard ratios
(HR) with CI of 95%.
The association between nutritional status (component in
NRS-2002), severity of disease (component in NRS-2002),
inﬂammation and the patient hydration status and the outcome
variable albumin (< 34 g/L) was investigated with logistic
regression analysis (the “Enter method”). As an indication of
inﬂammation a CRP cut-off value of 10 was chosen [31] and in-
dicators for hydration status were peripheral edema, ascites and
congestion on chest X-ray.3. Results
3.1. Characteristics of the study sample
The study sample consisted of 131 patients, 42 (32.1%) were
women. The median age was 78 years, range 37e95. 16% of the
patients were classiﬁed in NYHA-class II, 64.1% in NYHA-class III
and 19.9% in NYHA-class IV. In all, 80% of the patients used beta-
blockers and 82% ACE-inhibitors at the time of screening.
The group of excluded patients (N ¼ 157) had a similar gender
distribution (48.3% women), but they were older (median 82 years
versus 78 years, P < 0.05) and had higher mortality during follow-
up (104 of 157 patients) than the patients in the study sample (69 of
131 patients) (P < 0.05). Adjusted for age, excluded patients did notTable 1
Characteristics of patients with NRS-2002 < 3 versus NRS-2002  3 (N ¼ 131).
NR
N (%) 56
Demographics:
Age (year) Median 70
Women N (%) 14
Men N (%) 42
Nutritional status:
Food intake  75%e N (%) 1 (
Weight loss  5%f N (%) 0
BMI  20.5 (kg/m2) N (%) 0
Heart failure status:
NYHA-class II N (%) 18
NYHA-class III N (%) 36
NYHA-class IV N (%) 2 (
EF (%) Median 33
Beta-blocker N (%) 42
ACE-inhibitor N (%) 46
Congestion chest X-ray N (%) 29
Ascites N (%) 0 (
Peripheral edema N (%) 29
Biochemical:
Albumin (g/L) Mean (SD) 38
Pre-albumin (g/L) Mean (SD) 0.2
CRP (mg/L) Median 9.5
Cholesterol ( 5.5 mmol/L) N (%) 4 (
Co-morbidity:
Renal failureCreat < 330 mmol/L N (%) 10
Diabetes N (%) 19
COPDdegreeI/II N (%) 8 (
Hypertension N (%) 22
NRS-2002¼ nutritional risk screening; EF¼ ejection fraction; NYHA¼ New York Heart As
*P < 0.05.
***P < 0.001.
a Signiﬁcance testing with Mann Whitney U test.
b Signiﬁcance testing with Chi-square test.
c Signiﬁcance testing with Independent T Test.
d Signiﬁcance testing with Fisher Exact Test.
e Food intake  75% the preceding week.
f Weight loss  5% last 1e3 month.have signiﬁcant higher odds for mortality compared to included
patients (OR 1.42; 95% CI 0.83e2.46, P ¼ 0.205).
The prevalence of nutritional risk according to NRS-2002
(score  3) was 57.3% (75 of 131 patients). All patients were
weighted in light clothing on a Seca digital scale at the time of the
initial screening. Table 1 shows the characteristics for non-risk
patients (NRS-2002 < 3) and risk patients (NRS-2002  3) at
screening time. Four of 75 patients at nutritional risk received oral
nutritional supplements. None of the patients were treated with
tube feeding or parenteral nutrition. In the discharge summary
none of the patients had an ICD-10 code for mild, moderate or
severe malnutrition.3.2. Prevalence and factors associated with three-year mortality
In all, 69 (52.6%) of the included patients died within the period
of three-year follow-up (Table 2).
Totally within three-year follow up more patients at nutritional
risk died (N ¼ 51) compared to patients not at risk (N ¼ 18),
P < 0.001 (Table 2). Mortality by year is presented in Table 2 and the
KaplaneMeier survival curves are shown in Fig. 2 (Log rank test
(Mantel Cox), Chi Square 18.40, P < 0.001). Fig. 3aed presents the
association between mortality and nutritional status and the three
individual components of nutritional status in NRS-2002.
In the adjusted logistic regression analysis the odds for three-
year mortality was more than ﬁve-fold higher in patients with
NRS-2002  3 (OR 5.85; 95% CI 2.10e16.24) (Table 3).S-2002 < 3 NRS-2002  3 P
(42.7) 75 (57.3)
.5 81 <0.001***a
(33.3) 28 (66.7) 0.135b
(47.2) 47 (52.8) 0.135b
2.2) 44 (97.8) <0.001***d
11 (100) 0.002**d
15 (100) <0.001***d
(85.7) 3 (14.3) <0.001***b
(42.4) 49 (57.6)
8.0) 23 (92)
30 0.015*a
(40.0) 63 (60.0) 0.201b
(43.0) 61 (57.0) 0.906b
(34.5) 55 (65.5) 0.077b
0) 3 (100) 0.260d
(40.8) 42 (59.2) 0.632b
.8 (3.3) 35.6 (4.2) <0.001***c
1 (0.56) 0.17 (0.62) <0.001***c
26 <0.001***a
66.7) 2 (33.3) 0.401d
(33.3) 20 (66.7) 0.235b
(50.0) 19 (50.0) 0.284b
44.4) 10 (55.6) 0.876b
(44) 28 (56) 0.820b
sociation; CRP¼ C-reactive protein; COPD¼ chronic obstructive pulmonary disease.
Table 2
Mortality the ﬁrst three years (1095 days) (N ¼ 131).
Total
N (%)
NRS-2002 < 3
N (%)
NRS-2002  3
N (%)
P
Participants 131 (100) 56 (42.7) 75 (57.3)
Mortality
Year 1 37 (100) 7 (18.9) 30 (81.1) <0.001a***
Year 2 16 (100) 4 (25.0) 12 (75.0) 0.260a
Year 3 16 (100) 7 (43.7) 9 (56.3) 0.931a
Total mortality within 3 years 69 (100) 18 (26.1) 51 (73.9) <0.001a***
NRS-2002 ¼ nutritional risk screening.
***P < 0.001.
a Signiﬁcance testing with Chi-square test.
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gender, beta-blocker, ACE-inhibitor, albumin and renal failure, NRS-
2002 was associated with increased mortality (HR 2.78; 95% CI
1.53e5.03). The association between mortality and the three
components of NRS-2002 (poor nutritional status, high severity of
disease and age  70 years) was also studied in adjusted hazard
regression analyses (Table 4). The analyses showed that poor
nutritional status (HR 1.82; 95% CI 1.03e3.22), high severity of
disease (NYHA-class IV) (HR 1.78; 95% CI 1.00e3.16) and age  70
years (HR 3.24; 95% CI 1.48e7.10) were associated with mortality.
Including age as a continuous variable in the adjusted analysis, the
coefﬁcients for nutritional status and severity of disease did not
change. HR (95% CI) for three year mortality was for age per year
1.06 (1.03e1.09; P < 0.001).
Cox proportional hazard regression analyses were also used to
examine the association between mortality and the individual
components of nutritional status in NRS-2002. The analysis was
adjusted for the same independent variables as presented in
Table 4. HR (95% CI) for three year mortality was for food intake
( 75% of normal requirement in the preceding week) 1.35
(0.72e2.51; P ¼ 0.345), for weight loss ( 5% last 1e3 months) 2.66
(1.09e6.48; P ¼ 0.031), and for BMI  20.5 5.25 (2.23e12.35;
P < 0.001). All Cox proportional hazard regression analyses were
adjusted for level of albumin (< 34 g/L or not), which was inde-
pendently associated with increased mortality.
In the supplementary adjusted logistic regression analysis of
low albumin (< 34 g/L), neither CRP (cut-off 10 mg/L), congestionFig. 2. KaplaneMeier plot: days of survival up to three years (1095 days) in the group
of patients not at nutritional risk (NRS-2002 < 3) and in the group of patients at
nutritional risk (NRS-2002  3). Log rank test (Mantel Cox), Chi Square 18.40, P < 0.001.on chest X-ray, ascites, peripheral edema or severity of disease
(NYHA-class IV) were associated with the outcome, only the
nutritional component of NRS-2002 (OR 1.81; 95% CI 1.12e2.93;
P ¼ 0.015) was associated with low albumin.4. Discussion
In the present study, 131 hospitalized patients with CHF were
evaluated for nutritional risk by NRS-2002. The prevalence of
nutritional risk was 57%. Nutritional risk deﬁned by NRS-2002 was
an independent risk factor predicting three-year mortality in
adjusted analyses. The three components in NRS-2002 (nutritional
status, severity of disease, age) were all independently associated
with higher mortality.4.1. Nutritional risk and mortality in chronic heart failure patients
The prevalence of nutritional risk in hospitalized patients with
CHF has in studies differed from 34 to 90% [16e20], partly due to
methodological differences, the screening tool used and groups of
patients assessed. Thus, the prevalence of nutritional risk in the
present sample is in the range of previous studies. To our knowl-
edge this is the ﬁrst study using NRS-2002 to investigate the as-
sociation between nutritional risk and long-term mortality in
hospitalized patients with CHF. In our study, the mortality rate was
signiﬁcantly higher in patients at nutritional risk than in patients
not at nutritional risk.
In bivariate analyses, we found that patients at nutritional risk
had increased mortality mainly during the ﬁrst year after discharge
fromhospital. These results indicate that CHF patients at nutritional
risk are a very vulnerable patient group. We included mostly very
old patients, thus, three years may be a long follow up time, and
may also partly explain the high mortality within one year in this
analysis.
Furthermore, in adjusted analyses we found that CHF patients at
nutritional risk (NRS-2002 3) hadmore than ﬁve-time higher risk
of death during three-year follow up than non-risk patients.
Moreover, in Cox multivariate analysis where time to death was
taken into consideration, the CHF patients at nutritional risk were
more likely to die prior to those not being at nutritional risk in the
three-year follow-up period also after adjusting for co-morbidity
variables and gender. In line with our result, three previous
studies exploring the impact of poor nutritional conditions on
mortality in hospitalized CHF patients, found that poor nutritional
condition was an independent predictor of long term mortality
(two and three year) [16e18]. In total 68% of the CHF patients at
nutritional risk had died during three years follow up and this is in
the upper range of previous studies where the mortality was found
to be between 26.5e42% [17] and 35.9e76% [16] in CHF patients
with a poor nutritional condition (including the components at
“nutritional risk” and “malnourished”). However, these studies
Fig. 3. aed: KaplaneMeier plot: Days of survival up to three years (1095 days). aed presents the association between mortality, nutritional status and the three individual
components of nutritional status in NRS-2002. a: Normal nutritional status (score 0) versus score 1, 2 or 3 on nutritional status in NRS-2002. Log rank test (Mantel Cox), Chi Square
10.243, P < 0.001. b: Food intake > 75% versus  75% of normal requirement in preceding week. Log rank test (Mantel Cox), Chi Square 0.00, P ¼ 0.985. c: Weight loss < 5% versus
 5% last 1e3 months. Log rank test (Mantel Cox), Chi Square 2.757, P ¼ 0.097. d: BMI > 20.5 versus  20.5. Log rank test (Mantel Cox), Chi Square 24.012, P < 0.0001.
K. Tevik et al. / Clinical Nutrition ESPEN 12 (2016) e20ee29 e25used the MNA [16,17] and not NRS-2002. Furthermore, Aggarwal
et al. [17] investigated the nutritional condition in a sample of pa-
tients with decompensated advanced heart failure. We included
CHF patients with either decompensated or compensated chronic
heart failure, and our samplemay therefore not be fully comparable
with Aggarwal et al.'s sample of severe heart failure patients [17].
Our sample is to a greater extent comparable with Bonilla-Palomas
et al.'s study [16]. They included both decompensated and
compensated patients with CHF. Furthermore, CHF patients in their
study were diagnosed according to the recommendation of the
European Society of Cardiology [26], which is in line with diag-
nostic criteria used in our study.
According to the results in our study, we can conclude that NRS-
2002 is a non-invasive and inexpensive tool to be recommended as
part of routine nutrition screening of CHF patients at hospital
admittance. The high prevalence of nutritional risk and three-year
mortality rate in this patient group, indicate that early identiﬁca-
tion of CHF patients at nutritional risk and implementation of
nutritional support are relevant to prevent malnutrition [21,22].Whether nutritional support has effect on clinical outcome in CHF
patients at nutritional risk are, however, still unknown [32]. In our
study none of the risk patients were diagnosed with malnutrition
(mild, moderate or severe) in the discharge summary, and only four
of the patients at nutritional risk had, according to the records,
received nutritional support (oral nutritional supplements). When
this present study was conducted, nutritional screening was not a
routine in our department at St. Olav's Hospital. It has been shown
that in the absence of a formal screening procedure, malnourished
patients tend to be both under diagnosed and under treated
[33,34]. This could possibly explainwhy none of the risk patients in
our sample were diagnosed and why so few patients at nutritional
risk received nutritional treatment. However, we cannot rule out
the possibility that some patients were given oral nutritional sup-
plements without it being recorded. Nevertheless, our results
emphasize the need for systematic nutritional screening of CHF-
patients. Nutritional risk has to be identiﬁed before it can be
treated. Since themean hospital stay is short for CHF patients [24] it
is important that the patients, community or another institution
Table 3
Relationship between three years mortality and nutritional risk (NRS-2002  3 versus not) in unadjusted and adjusted logistic regression analyzes.
Unadjusteda LRA Adjustedb LRA
OR 95% CI P OR 95% CI P
NRS-2002  3 4.49 2.14e9.42 <0.001*** 5.85 2.10e16.24 0.001***
Gender (man) 0.58 0.27e1.22 0.148 0.53 0.20e1.40 0.199
EF  30% 0.59 0.30e1.18 0.134 0.62 0.24e1.58 0.315
Beta-blocker 1.93 0.79e4.71 0.151 3.65 1.12e11.83 0.031*
ACE-inhibitor 4.33 1.51e12.45 0.006** 4.35 1.13e16.66 0.032*
Albumin < 34 g/L 5.43 2.05e14.40 0.001*** 3.04 0.99e9.33 0.052
Pre-albumin < 0.26 g/L 1.26 0.48e3.34 0.640
CRP > 10 mg/L 1.50 0.65e3.45 0.350
Cholesterol  5.5 mmol/ml 0.89 0.17e4.60 0.893
Renal failure 4.98 1.87e13.22 0.001*** 4.97 1.57e15.76 0.006**
Diabetes 1.35 0.63e2.88 0.445
COPD degree I/II 1.97 0.69e5.60 0.206
Hypertension 1.09 0.54e2.21 0.811
LRA ¼ logistic regression analyzes; OR ¼ odds ratio; CI ¼ conﬁdence interval; NRS-2002 ¼ nutritional risk screening; CRP ¼ C-reactive protein; COPD ¼ chronic obstructive
pulmonary disease; ACE ¼ angiotensin-converting-enzyme.
*P < 0.05.
**P < 0.01.
***P < 0.001.
a Unadjusted logistic regression analyzes. Independent variables included separately. Dependent variable: Three years mortality. Independent variables: NRS-2002
(score < 3 reference category), gender (woman reference category), EF (> 30% reference category), beta-blocker, ACE-inhibitor, albumin ( 34 g/L reference category), pre-
albumin ( 0.26 g/L reference category), cholesterol (< 5.5 mmol/ml reference category), renal failure with creatinine < 330 mmol/L, diabetes, COPD degree I/II, hypertension.
b Adjusted logistic regression analysis. The variables included in the unadjusted analyzes with P < 0.20 were used.
Table 4
Adjusted hazard ratio (Cox multivariate analysis) for overall three year mortality in the study sample (N ¼ 131).
Crude HR (95% CI) P Adjusted HR (95% CI) P
NRS-2002  3 3.09 (1.79e5.27) <0.001***
Nutritional status 2.28 (1.38e3.76) 0.002** 1.82 (1.03e3.22) 0.039*
Severity of disease 1.85 (1.09e3.20) 0.029* 1.78 (1.00e3.16) 0.047*
Age  70 year 5.05 (2.41e10.59) <0.001*** 3.24 (1.48e7.10) 0.003**
Gender (man) 0.70 (0.43e1.14) 0.153 0.77 (0.44e1.33) 0.345
EF  30% 0.77 (0.48e1.23) 0.274
Beta-blocker 1.51 (0.88e2.62) 0.151 2.14 (1.17e3.94) 0.014*
ACE-inhibitor 2.30 (1.35e3.90) 0.003** 1.67 (0.92e3.02) 0.089
Albumin < 34 g/L 3.04 (1.84e5.00) <0.001*** 2.05 (1.21e3.47) 0.007**
Pre-albumin < 0.26 g/L 1.18 (0.58e2.38) 0.646
CRP > 10 mg/L 1.32 (0.76e2.32) 0.330
Cholesterol  5.5 mmol/ml 0.72 (0.23e2.29) 0.576
Renal failure 2.33 (1.41e3.83) <0.001*** 1.71 (0.93e3.13) 0.083
Diabetes 1.19 (0.72e1.97) 0.502
COPD degree I/II 1.34 (0.72e2.49) 0.361
Hypertension 0.99 (0.61e1.62) 0.986
HR ¼ hazard ratio, CI ¼ conﬁdence interval, NRS-2002 ¼ nutritional risk screening, EF ¼ ejection fraction; ACE ¼ angiotensin-converting-enzyme; CRP ¼ C-reactive protein;
COPD ¼ chronic obstructive pulmonary disease.
*P < 0.05.
**P < 0.01.
***P < 0.001.
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future nutrition care [21].
The NRS-2002 consists of three components (nutritional status,
severity of disease and age) [21,22]. In the additional adjusted Cox
regression analysis performed, we found that each of the three
components in NRS-2002 independently were associated with long
term mortality.
We found that poor nutritional status almost doubled the risk
for early mortality, independent of the age and severity of the heart
failure. A complex interplay of hormonal systems, malabsorption,
dietary deﬁciencies, anorexia and early satiety may inﬂuence the
nutritional status of heart failure patients [10,11,13]. Nutritional
status in NRS-2002 is evaluated by three individual components:
food intake, weight loss and BMI [21,22]. In our studywe found that
reduced food intake ( 75% of normal requirement the preceding
week) was common in CHF patients at nutritional risk (Table 1).However, reduced food intake was not associated with mortality in
adjusted analyses. This result is somewhat surprising since a study
performed in 3279 patients in a Norwegian university hospital
found that patients with reduced food intake during the last week
had OR 1.72 (95% CI 1.03e2.85) for one year mortality [35]. The
patients in that study had a wide variety of diseases and may
therefore not be comparable with our sample. On the other hand,
the individual components of low BMI ( 20.5) and weight loss
( 5% last 1e3 months) were associated with mortality in adjusted
analyses. Thus our result support the term “obesity paradox”
observed in CHF-patients, which means that patients with higher
BMI have a lowermortality risk, and patients with lower BMI have a
higher mortality risk [5,6,12e14]. In addition our result is in line
with Anker et al.'s observational studies which indicated that
weight loss in CHF-patients was an independent risk factor of
mortality [10,11]. The higher mortality among patients with low
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energy intake, malnutrition and cardiac cachexia [12]. In our study
all patients with either low BMI (15 of 131) or weight loss (11 of
131) were classiﬁed at nutritional risk (NRS-2002  3).
Furthermore, we found in adjusted analysis that patients with
high severity of their heart failure (NYHA class IV versus not) had
almost double the risk for mortality as those with less serious
severity of the disease. The present result is consistent with pre-
vious studies of CHF patients that have found that higher NYHA-
class was associated with two-year [5] and three-year [6] mortal-
ity. However, baseline assessment in these studies was not con-
ducted in hospitalized patients.
High age ( 70 years) increased the risk for mortality more than
threefold. Age per year was also associated with three year mor-
tality. In previous studies age has also been shown to be a powerful
predictor of mortality in patients with CHF [5,6].
In addition, hypoalbuminemia was associated with higher
mortality in our sample. Other studies have found an evident
association between hypoalbuminemia and mortality in CHF
patients [36,37]. Use of albumin may add valuable information of
mortality risk to NRS-2002. This needs further study. Albumin
has a half-life around 20 days [38] and is inﬂuenced by several
factors like malnutrition [37], chronic inﬂammation [37],
increased vascular permeability [36] and the patient's hydration
state [38]. In our sample low plasma level of albumin was only
associated with the patient nutritional status. However we did
not ﬁnd an interaction between nutrition and albumin for mor-
tality. The serum protein pre-albumin has a half-life of 48 h [38]
and may reﬂect a more recent picture of the patient's nutritional
condition [38]. It could be of value to measure albumin and pre-
albumin routinely as part of the clinical assessment of the CHF
patients. We did not ﬁnd an association between pre-albumin at
inclusion and three-year mortality. A previous study has found a
signiﬁcant association between low discharge pre-albumin
( 15 mg/dl) and 6 months mortality in hospitalized heart fail-
ure patients [39]. Unfortunately, we did not have any discharge
measures.
4.2. NRS-2002 and long term predictive value
Thus, nutritional risk assessed with NRS-2002 had importance
for long-term mortality in patients with CHF. As previously
mentioned, the results from the present study are quite consistent
with other studies of CHF patients using other screening tools. In
addition our results are consistent with studies using NRS-2002 to
study the association between mortality and samples of hospi-
talized patients in general [35,40]. However, the studies of general
samples of hospitalized patients had shorter follow up period, i.e.
6 months [40] and 12 months [35]. A small study conducted by
Holst et al. [25] in elderly hospitalized patients with a wide range
of diagnoses, did not ﬁnd an association between nutritional risk
and 12 month mortality. Thus, the results are somewhat incon-
sistent. Further studies are needed to clarify and support our
ﬁndings according to long term mortality in hospitalized patients
with CHF and also in other hospitalized patient groups using NRS-
2002.
4.3. Strengths and limitations
According to Van Bokhorst-de van der Schueren [23] clinical
outcomes are inﬂuenced by factors other than nutritional status
alone. The author argues that clinical studies investigating the
importance of nutritional status, are of less value if they have not
adjusted for factors such as age, severity of disease and diagnoses
[23]. Therefore, a strength of our study is that we have adjusted forthese factors and other comorbidity variables when we investi-
gated the association between the component of nutritional status
in NRS-2002 and mortality. We ﬁnd it likely that nutritional status
has a separate inﬂuence on clinical outcome in patients with CHF as
found in the present study.
Another strength of our study is that we have information on
when all included patients died due to a complete Norwegian
Cause of Death Registry. Furthermore, no participant was lost to
follow-up.
However, there are several limitations to address. Firstly, the
study has a limited sample size. Low sample size limits statistical
power. Furthermore, the study was a single center study with a
somewhat selected sample (Fig. 1). Thus, the results should be
interpreted with caution.
Secondly, a limitation of our study is the heterogeneous sample
according to age and severity of disease, which are two key factors
for mortality in patients with CHF [5,6]. The age range (37e95
years) is large. Since we included both decompensated and
compensated patients with CHF, we also had a wide range in the
severity of disease (NYHA classiﬁcation from II to IV). Thus, even if,
poor nutritional status, was adjusted for severity of disease, we
cannot rule out the possibility of rest confounding due to the
sample heterogeneity.
Thirdly, frailty [9], functional decline, social isolation and
declined cognitive function may inﬂuence the mortality rate in
elderly persons [41]. However, we were not able to adjust for these
factors. Frailty is probably also related to poor food intake. In
addition we could not adjust for NT-proBNP, a known predictor of
mortality in patients with CHF [7]. Even so, we think it is unlikely
that this have affected the relationship between nutritional risk and
mortality, because NT-proBNP is strongly associated with the
severity of heart failure (NYHA-classiﬁcation) [8,42], which is
adjusted for in the analyses.
Fourthly, inﬂammation and hydration factors associated with
low plasma level of albumin, is of interest to better understand
the importance of albumin in the present study. A measure of
hemoglobin, hematocrit, sodium and osmolality in serum would
have been better indicators for the patient hydration status [43]
than we used, but unfortunately we do not have such
information.
Fifthly, the analyses would have been more powerful if nutri-
tional screenings were done at regular intervals during the hospital
stay and at discharge. Unfortunately the nutritional screening was
just done at baseline. In addition, our assessment of disease severity
was based on the patients NYHA-classiﬁcation [28] and with
Kondrup et al.'s prototype of score on severity of disease [22]. This
scoring system is not validated in patients with CHF, and needs
further investigation.
Lastly, we used one screening tool for evaluating the nutritional
risk of hospitalized patients with CHF. A comparison of the results
using another screening tool, e.g. MNA, SGA and MUST [21] could
have increased the impact of our study.
5. Conclusion
In summary, the results of the present study show a high
prevalence of nutritional risk (NRS-2002 score  3) in hospitalized
patients with CHF. The nutritional risk state as deﬁned by NRS-
2002 was associated with increased mortality and was an inde-
pendent predictor of three-year mortality in multivariate analysis.
Poor nutritional status, high severity of disease, and high age ( 70
year), i.e. all components in NRS-2002, were independently asso-
ciated with mortality. Screening of nutritional risk should therefore
be integrated as a part in the overall assessment of hospitalized
patients with CHF.
K. Tevik et al. / Clinical Nutrition ESPEN 12 (2016) e20ee29e28Statement of authorship
KT carried out the study and data analyses and drafted the
manuscript. HT gave statistical advice and drafted the manuscript.
MIH participated in the data collection and helped to draft the
manuscript. AKS participated in the data collection and helped to
draft the manuscript. ASH participated in the study design, gave
statistical advice and drafted the manuscript. All authors have read
and approved the ﬁnal manuscript.
Conﬂict of interest statement
There is no ﬁnancial conﬂict of interest for any of the authors.
Funding sources
This study received ﬁnancial support from St. Olav's University
Hospital, Norway.
Acknowledgments
Thanks to the clinic manager, dr.med, Rune Wiseth, dr.med,
Johannes Soma, Head of Nursing, Gunn Husby and Gustav
Østerberg Øverli at the Department of Cardiology, St. Olav's Uni-
versity Hospital for valuable advice and support. We also want to
thank Anita Stordal, Ingegerd Iversen, nurses and doctors at the
Department of Cardiology for help with the data collection. Thanks
also toMariana H€arm€al€a, Brenda Strand and Ph.D., Lene Thoresen at
St. Olav's University Hospital.
References
[1] Lindenfeld J, Albert NM, Boehmer JP, Collin SP, Ezekowitz JA, Giverts MM, et al.
HFSA 2010 comprehensive heart failure practice guideline. J Card Fail
2010;16(6):e1e194.
[2] McMurray JJV, Adamapoulos S, Anker SD, Auricchio A, B€ohm M, Dickstein K,
et al. ESC guidelines for the diagnosis and treatment of acute and chronic
heart failure 2012: the task force for the diagnosis and treatment of acute and
chronic heart failure 2012 of the European Society of Cardiology. Developed in
collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J
2012;14(8):803e69.
[3] Sargento L, Longo S, Lousada N, dos Reis RP. The importance of assessing
nutritional status in elderly patients with heart failure. Curr Heart Fail Rep
2014;11(2):220e6.
[4] Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93(9):
1137e46.
[5] Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al.
Predictors of mortality and morbidity in patients with chronic heart failure.
Eur Heart J 2006;27:65e75.
[6] Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, et al. Pre-
dicting survival in heart failure: a risk score based on 39 372 patients from 30
studies. Eur Hear J 2013;34(19):1404e13.
[7] Greene SJ, Maggioni AP, Fonarow GC, Solomon SD, B€ohm M, Kandra A, et al.
Clinical proﬁle and prognostic signiﬁcance of natriuretic peptide trajectory
following hospitalization for worsening chronic heart failure: ﬁndings from
the ASTRONAUT trial. Eur Heart Fail 2015;17(1):98e108.
[8] Zhang S, Hu Y, Zhou L, Chen X, Wang Y, Wu J, et al. Correlations between
serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic
peptide levels in elderly patients with chronic heart failure (CHF). Arch Ger-
ontol Geriatr 2015;60(2):359e65.
[9] Uchmanowicz I, Loboz-Rudnicka M, Szelag P, Jankowska-Polanska B,
Loboz-Grudzien K. Frailty in heart failure. Curr Heart Fail Rep 2014;11(3):
266e73.
[10] Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, et al.
Prognostic importance of weight loss in chronic heart failure and the effect of
treatment with angiotensin-converting-enzyme inhibitors: an observational
study. Lancet 2003;361(9363):1077e83.
[11] Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al.
Wasting as independent risk factor for mortality in chronic heart failure.
Lancet 1997;349:1050e3.
[12] Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM,
McAlister FA. Body mass index and mortality in heart failure: a meta-analysis.
Am Heart J 2008;156(1):13e22.
[13] Güder G, Frants S, Bauesachs J, Allolio B, Wanner C, Koller MT, et al. Reverse
epidemiology in systolic and non-systolic heart failure: cumulative prognosticbeneﬁt of classical cardiovascular risk factors. Circ Heart Fail 2009;2(6):
563e71.
[14] Sharma A, Lavie CJ, Borer JS, Vallakati A, Goel S, Lopez-Jimenez F, et al. Meta-
analysis of the relation of body mass index to all-cause and cardiovascular
mortality and hospitalization in patients with chronic heart failure. Am J
Cardiol 2015;115(10):1428e34.
[15] Greene SJ, Vaduganathan M, Lupi L, Ambrosy AP, Mentz RJ, Konstam MA, et al.
Prognostic signiﬁcance of serum total cholesterol and triglyceride levels in
patients hospitalized for heart failure with reduced ejection fraction (from the
EVEREST Trial). Am J Cardiol 2013;111(4):514e81.
[16] Bonilla-Palomas JL, Gamez-Lopez AL, Anguita-Sanchez MP, Castillo-
Dominguez JC, Garcia-Fuertes D, Crespin-Crespin M, et al. Impact of malnu-
trition on long-term mortality in hospitalized patients with heart failure. Rev
Esp Cardiol 2011;64:752e8.
[17] Aggarwal A, Kumar A, Gregory MP, Blair C, Pauwaa S, Tatooles AJ, et al.
Nutrition assessment in advanced heart failure patients evaluated for ven-
tricular assist devices or cardiac transplantation. Nutr Clin Pract 2013;28(1):
112e9.
[18] Narumi T, Arimento T, Funayama A, Kadowaki S, Otaki Y, Nishiyama S, et al.
The prognostic importance of objective nutritional indexes in patients with
chronic heart failure. J Cardiol 2013;62(5):307e13.
[19] Yost G, Gregory M, Bhat G. Short-form nutrition assessment in patients with
advanced heart failure evaluated for ventricular assist device placement or
cardiac transplantation. Nutr Clin Pract 2014;29(5):686e91.
[20] Aziz EF, Javed F, Pratap B, Musat D, Nader A, Pulimi S, et al. Malnutrition as
assessed by nutritional risk index is associated with worse outcome in pa-
tients admitted with acute decompensated heart failure: an ACAP-HF data
analysis. Heart Int 2011;6(1):e2.
[21] Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutri-
tion screening 2002. Clin Nutr 2003;22:415e21.
[22] Kondrup J, Rasmussen HH, Hamberg O, Stanga Z, Ad Hoc ESPEN Working
Group. Nutritional risk screening (NRS 2002): a new method based on an
analysis of controlled clinical trials. Clin Nutr 2003;22:321e36.
[23] Van Bokhorst-de van der Schueren MAE, Guaitoli PR, Jansma EP, de
Vet HC. Nutrition screening tools: does one size ﬁt all? A systematic re-
view of screening tools for the hospital setting. Clin Nutr 2014;33(1):
39e58.
[24] Tevik K, Thürmer H, Husby IM, de Soysa AS, Helvik AS. Nutritional risk
screening in hospitalized patients with heart failure. Clin Nutr 2015;34(2):
257e64.
[25] Holst M, Yifter-Lindgren E, Surowiak M, Nielsen K, Mowe M, Carlsson M.
Nutritional screening and risk factors in elderly hospitalized patients: asso-
ciation to clinical outcome? Scand J Caring 2013;27(4):953e61.
[26] Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al.
Guidelines for the diagnosis and treatment of chronic heart failure: executive
summary (update 2005): the task force for the diagnosis and treatment of
chronic heart failure of the European Society of Cardiology. Eur Heart J
2005;26(11):1115e40.
[27] International statistical classiﬁcation of diseases and related health problems
10th revision (ICD-10) eWHO version for. Accessed 21.10.15, at: http://apps.
who.int/classiﬁcations/icd10/browse/2016/en#/I30-I52; 2016.
[28] The Criteria Committee of the New York Heart Association. Diseases of the
heart and blood vessels; nomenclature and criteria for diagnosis. 9th ed.
Boston: Little Brown; 1994.
[29] St. Olav's University Hospital in Trondheim, Norway. Department of Medical
Biochemistry. Analyses and surveys. Accessed 18.02.14, at: http://www.stolav.
no/no/Om-oss/Avdelinger/Medisinsk-biokjemi/Fagfolk/.
[30] Stensland SH, Margolis S. Simplifying the calculation of body mass index for
quick reference. J Am Diet Assoc 1990;90(6):856.
[31] Drescher T, Singler K, Ulrich A, Koller M, Keller U, Christ-Crain M, et al.
Comparison of two malnutrition risk screening methods (MNA and NRS 2002)
and their association with markers of protein malnutrition in geriatric hos-
pitalized patients. Eur J Clin Nutr 2010 Aug;64(8):887e93.
[32] Gamez-Lopez AL, Bonilla-Palomas JL, Anguita-Sanchez M, Moreno-
Conde M, Lopez-Ibanez C, Alhambra-Exposito R, et al. Rationale and
design of PICNIC study: nutritional intervention program in hospitalized
patients with heart failure who are malnourished. Rev Esp Cardiol
2014;67(4):277e82.
[33] Bavelaar JW, Otter CD, van Bodegraven AA, Thijs A, van Bokhorst-de van der
Schueren MA. Diagnosis and treatment of (disease-related) in-hospital
malnutrition: the performance of medical and nursing staff. Clin Nutr
2008;27:431e8.
[34] Mowe M, Bohmer T. The prevalence of undiagnosed protein-calorie under-
nutrition in a population of hospitalized elderly patients. J Am Geriatr Soc
1991;39(11):1089e92.
[35] Tangvik RJ, Tell GS, Eisman JA, Guttormsen AB, Henriksen A, Nilsen RM, et al.
The nutritional strategy: four questions predict morbidity, mortality and
health care costs. Clin Nutr 2014;33(4):634e41.
[36] Bonilla-Palomas JL, Gamez-Lopez AL, Moreno-Conde M, Lopez-Ibanez MC,
Anguita-Sanchez M, Gallego de la Sacristana A, et al. Hypoalbuminemia in
acute heart failure patients: causes and its impact on hospital and long-term
mortality. J Card Fail 2014;20(5):350e8.
[37] Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels
predict survival in patients with systolic heart failure. Am Heart J
2008;155(5):883e9.
K. Tevik et al. / Clinical Nutrition ESPEN 12 (2016) e20ee29 e29[38] Devoto G, Gallo F, Marchello C, Racchi O, Garbarini R, Bonassi S, et al. Pre-
albumin serum concentrations as a useful tool in the assessment of malnu-
trition in hospitalized patients. Clin Chem 2006;52(12):2281e5.
[39] Lourenco P, Silva S, Frio^es T, Alvelos M, Amorim M, Couto M, et al. Low pre-
albumin is strongly associated with adverse outcome in heart failure. Heart
2014;100(22):1780e5.
[40] Mercadal-Orﬁla G, Lluch-Taltavull J, Campillo-Artero C, Torrent-Quetglas M.
Association between nutritional risk based on the NRS-2002 test and hospital
morbidity and mortality. Nutr Hosp 2012;27(4):1248e54.[41] Dent E, Visvanathan R, Piantadosi C, Chapman I. Nutritional screening tools as
predictors ofmortality, functional decline, andmove tohigher level care in older
people: a systematic review. J Nutr Gerontol Geriatr 2012;31(2):97e145.
[42] Lu Z, Wang B, Wang Y, Qian X, Zheng W, Wei M. Relationship between CCR
and NT-proBNP in Chinese HF patients, and their correlations with severity of
heart failure. Biomed Res Int 2014:1e7.
[43] European hydration institute. Assessing hydration status. Accessed 26.01.16,
at: http://www.europeanhydrationinstitute.org/human-hydration/assessing-
hydration-status/#.
